<DOC>
	<DOCNO>NCT02742805</DOCNO>
	<brief_summary>The propose research intend determine supplementation relatively high dose vitamin D chronic urticaria patient receive omalizumab result continue symptomatic control hive discontinuation omalizumab .</brief_summary>
	<brief_title>Sustained Effect Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation</brief_title>
	<detailed_description />
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>Physician diagnose chronic urticaria Currently receive omalizumab therapy treatment chronic idiopathic urticaria well control USS &lt; 25 Not capable informed consent . Not capable answer questionnaire . Subjects pure physical urticaria . Pregnant lactating woman . Subjects hypercalcemia ( calcium &gt; 10.3 mg/dl ) renal insufficiency ( GFR &lt; 50 ml/min ) . Subjects prior anaphylaxis omalizumab . Currently take high dose vitamin D supplementation . Prior high dose vitamin D supplementation urticaria failure . Baseline 25 ( OH ) D &gt; 80 ng/ml Subjects sarcoidosis , hyperparathyroidism , histoplasmosis , lymphoma tuberculosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hive</keyword>
</DOC>